Alzheimer's disease pathophysiology Flashcards

1
Q

What changes can happen in the brain in AD?

A
  • Atrophy (decline/decrease) in the cerebral cortex and hippocampus by 15-20%
  • Sulci widened (groove in the cerebral cortex) = bigger gaps = decreased surface area = decreased grey matter and leads to neuronal cell loss.
  • Formation of extracellular plaques between cells that contain β-amyloid peptide = missfolding and aggregation of proteins is considered pathogenic in many neurodegenerative conditions.
  • Formation of intra-neuronal neurofibrillary tangles composed of hyperphosphorylated tau protein
  • Functional losses in neurotransmitters- loss in cholinergic, GABAergic, monoaminergic transmitter systems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where do the first changes in the brain occur?

A

In the hippocampus and the frontal cortex = these occur pre-clinically (before symptoms present). Overtime, Changs spread to over most of the brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How is β- amyloid produced?

A

β-amyloid is a 36-43 amino acid peptide is produced from the amyloid precursor protein (APP) by the action of secretases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is APP?

A

Amyloid precursor protein- a large transmembrane glycoprotein (77 aa) found in many cells.
Cleavage of APP gives roles in:
Transcriptional regulation
Growth factor function
Synaptic transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the different enzymes that cleave APP (Amyloid precursor protein)?

A

𝛼-secretases
β-secretases
𝜸-secreteases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the process of B-amyloid production

A

APP is cleaved by alpha-secretase and the EC part forms soluble APP (SAPP)
This remainder of the protein can be cleaved by gamma-secretase within the transmembrane domain.
Cleavage by beta and gamma secretase leads to production of β-amyloid which is toxic ( the protein found between beta and gamma cleavage sites).
- Beta-amyloid forms plaques- Aβ40 and Aβ42
Aβ40 is most abundant
Aβ42 is more likely to form plaques though- as is insoluble and amyloidogenic
- mutations in APP affected where secretases can cut and so increase the proportion of Aβ42 = increased plauques
- Mutations in presenillin- the catalytic part of the 𝜸-secretase complex = increased 𝜸-secretease activity = increased β-amyloid plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the two types of beta-amyloid formed?

A

Aβ40 and Aβ42
Aβ40 is most abundant (80-90%)
Aβ42 is more likely to form plaques (10-20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are the β-amyloid plaques deposited and what do they cause?

A

The β-amyloid monomers combine to form oligomers. Oligomers combine to form fibrils.
Fibrils go on to form amyloid-β-plaques (these plaques also contain: microglia, astrocytes, apolipoproteins)

Soluble Aβ ogliomers:
- These are disruptive to signalling through the NMDA receptor = synaptic dysfunction
- Disrupts Long term potentiation (LTP) associated with memory
- They can cause neuronal cell death

Plaque-associated protein (apolipoproteins etc) incorporated into fibril to produce extracellular plaque:
- Can cause direct cytotoxic effects in neurones
- Also, initiate an inflammatory response: microglia activation = cytokine release = leads to mitochondrial damage and oxidative stress = neuronal cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the effect of neurofibrillary tangles on pathology of AD?

A

These neurofibrillary tangles are formed from hyperposphorylated Tau protein.
Normally Tau:
- involved in stabilisation of microtubules = important in axonal transport from one end of neurone to the other
- It binds to microtubules to stabilise them, then when TAU is phosphorylated, Tau is detached and dephosphorylation of microtubules occurs.
BUT, if TAU is hyperphosphorylated, it is no longer attatched to the microtubule and instead aggregates to form paired helical filaments. These lead to formation of neurofibrillary tangles = microtubules depolymerise = loss of axonal transport = neuronal cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the effect of changes in neurotransmitters on the pathology of AD?

A

Most important is the changes to the cholinergic pathways which are widely distributed.
Acetylcholine is involved in discrete pathways:
- Cell bodies in the nucleus basalis project their axons to the cortex and synapse with cortical neurones
- Septical nucleus project to the hippocampus- role in memory
- Brainstem ti the thalamus- involved in motor control
- Cholinergic interneurones in the striatum- involved in motor control

  • Ach has roles in arrousal (wakeness) and reward pathways- involves nicotinic receptors, hence why nicotine is so addictive as it also acts at the acetylcholine receptors
  • In AD, the frist 2 pathways above are most affected hence the decrease in memory and cognition in AD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the effect of neurochemical changes in the brain on the pathology of AD?

A
  • Post-mortem brain tissue has shown a loss of cholinergic neurones in the basal forebrain ( nucleus basalis to cortex) and hippocampus ( from septal nucleus) = decreased cognition, learning and memory.
  • Reduced choline acetyltransferase activity (50-90% decrease)- responsible for making Act
    Also, there is a decrease in Acetylcholine esterase, choline transport and nicotinic receptor density in the cortex = all lead to decrease Ach concs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why do people with Down syndrome have an increased risk of AD?

A

Downs syndrome predisposes a patient to AD as the Amyloid precursor protein is located on chromosome 21. DS has 3 copies of this chromosome and so there is a higher expression of APP = more β-amyloid = increased plaque formation that leads to AD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some mutations that can cause early onset AD?

A
  • APP (amyloid precursor protein)- mutations tend to occur at the cleavage sites of β and 𝜸 secretase- meaning cleavage occurs at the wrong positions, that favours Aβ42- This is more amyloidogenic = more plaques
  • Mutations in presenilin genes (PSEN1 & PSEN2): This is a transmembrane protein that regulates the catalytic part of 𝜸-secretase. Mutations here, lead to an increase in Aβ42 and therefore increased plaque formation. This is the most common mutation seen in early-onset AD
  • TAU mutations- leads to increased phosphorylation of TAU.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is early-onset AD?

A

This is AD that presents younger than 60 years old- accounts for 5% of AD cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the genetic basis of late-onset AD?

A

Mutations in the APOE gene- a lipid-binding lipoprotein involved in transport of lipids. Also, Apolipoprotein is found in the plaques and is thought to have a role in plaque clearance- APOE4 is less effective at clearing these plaques.
- There are 4 variants of this gene- 1,2,3 and 4.
We inherit 1 allele from our mother and 1 allele from our father
APOE-4 is strongly linked to AD- so inheriting 2 APOE4 alleles (apoe4 from both mother and father) = increased incidence of AD
- APOE2 shoes the lowest risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What alleles of the APOE gene have highest and lowest risk of AD?

A

Carrying 2 APOE4 alleles gives the highest risk
- APOE2 reduces the risk

17
Q

What are the 2 classes of drugs used in AD?

A

Acetylcholine esterase inhibitors e.g. Donepezil, Rivastigmine, galantamine

NMDA antagonist- memantine

18
Q

How do acetylcholine esterase inhibitors work in AD?

A

In AD, there is a selective loss of cholinergic neurones.
By using acetylcholine esterase inhibitors there is an increased concentration of acetylcholine in the synapse, leading to increased downstream activity to make up for neuronal loss

19
Q

What does Galantamine block in addition to acetylcholine esterase?

A

Also blocks Butylcholine esterase enzyme that also breaks down acetylcholine.

20
Q

What other activity does galantamine have over the other acetylcholine esterase inhibitors?

A
  • Also blocks Butylcholine esterase enzyme that also breaks down acetylcholine.
  • Also, it is a positive allosteric modulator at nicotinic receptors = enhanced activity of receptors and downstream activity of nicotinic receptors = increased release of acetylcholine
    Pre-synaptic nicotinic receptors have positive feedback mechanisms = acetylcholine release causes an increase in release
21
Q

How effective are acetylcholine esterase inhibitors in improving cognitive function in AD?

A

These drugs have a small improvement in cognitive function in mild-moderate AD.
Their action requires some intact cholinergic neurones to synthesise Ach = hence they are more beneficial in early stages.

22
Q

How do NMDA antagonists (Memantine) work in AD?

A

Memantine are non-competitive antagonists at NMDA receptors.
Inhibiting NMDA receptors = decrease in excitotoxicity:
- When glutamate is in excess, it has excitotoxicity
Excess glutamate causes neuronal function to deteriorate = this causes neuronal cell death and plays a role in AD.
These neuronal cells release glutamate when they die, this leads to a secondary cell death.

Memantine decreases excitotoxicity = decreases neuronal cell death = cognitive improvement in moderate-severe disease.

23
Q

What sorts of side effects would you expect to see in the Acetylcholine esterase inhibitors and why?

A

Anti-cholinesterase drugs increase the drive of the parasympathetic nervous system = increase in secretions from glands and rest and digest processes.
Due to an increase in acetylcholine due to lack of breakdown via acetylcholine esterase:
- Ach acts at M3 receptors:
Stimulates peristalsis and movement of water into the stool = diarrhoea
- further secretions from endocrine glands e.g. saliva, stomach acid (dyspepsia- H1 receptors), urine
- Ach acts on the cilliary muscles causing contraction of smooth muscle of the eye = constriction of pupil = can’t focus far away = blurrier vision
- Spasms/cramps: Increased Ach at the NMJ
- Bradycardia- decreased HR due to increased Ach acting on M2 receptors of the heart
- Abdo pain- contraction of sm
- more M1 activation - increased acid
- Ach also acts at nicotinic receptors on skeletal muscle = sweating (?)
- Urinary incontinence- contraction of bladder = relax and release urine

The inhibition of the enzyme leads to accumulation of ACh in the synaptic cleft resulting in over-stimulation of nicotinic and muscarinic ACh receptors and impeded neurotransmission